期刊文献+

miRNA表达谱在肾纤维化中的差异表达及抗纤灵的干预研究 被引量:5

Differential Expression of miRNA in Renal Fibrosis and Intervention of Kangxianling Decoction
下载PDF
导出
摘要 目的筛选观察在阿霉素肾病大鼠模型特异性miRNA表达谱,观察抗纤灵方干预的作用。方法将SD雄性大鼠随机分为6组,每组8只。其中假手术组仅于右侧肾切除,灌于生理盐水,余下40只SD大鼠均采取右侧肾切除加尾静脉注射阿霉素制备大鼠硬化模型。将造模成功后的大鼠分成模型组、科素亚组、抗纤灵低,中,高5组,分别给予相对应的药物共8周,观察各组大鼠肾脏组织TGF-β、Smad3 mRNA水平改变。同时对各组实验肾脏标本,运用miRNA高通量测序,检测miRNA表达谱,分析差异表达谱,观察抗纤灵方干预的作用。结果抗纤灵方对阿霉素肾病模型大鼠能降低TGF-β、Smad3 mRNA水平,差异有统计学意义(P <0.05)。随着抗纤灵剂量增加,其抗纤维化效应更明显,差异有统计学意义(P <0.05)。通过筛选miRNA表达谱,差异表达分析中发现假手术组与模型组表达谱差别最大,假手术组与抗纤灵高剂量治疗组差别最小。从差异表达分析中,观察到了药物处理剂量越大,样本的表达谱越与假手术组相近。结论抗纤灵方能改善肾纤维化,并且随着剂量增大抗纤维化的效果越好,推测其机制可能通过调节miRNA谱的差异表达,降低TGF-β、Smad3 mRNA水平,来改善肾纤维化。 Objective To observe the mechanism of Kangxianling Decoction and screen the specific miRNA expression profile on renal fibrosis of adriamycin-induced nephropathic rats.Methods SD male rats were randomly divided into 6 groups with 8 rats in each group.The sham operation group was treated with normalsaline only after right nephrectomy.The other 40 SD rats were treated with right nephrectomy and intravenous injection of adriamycin.The operation group was randomly divided into the model group,the Kangxianling Decoction low,medium and high dose group and the Losartan Potassium group.Corresponding drugs administered to rats in all groups for 8 weeks.After the treatment,the changes of TGF-βand Smad3 mRNA levels in kidney tissues of model rats were observed.For each group of experimental kidney specimens,miRNA high-throughput sequencing was used to detect miRNA expression profiles,analyze differential expression profiles,and observe the effects of anti-fibrosis intervention.Results Compared with the model group,Kangxianling Decoction could significantly lower the expression of TGF-βand Smad3(P<0.05).By increasing of the dose of Kangxianling Decoction,the anti-fibrosis effect was more obvious,and the difference was significant(P<0.05).By screening miRNA expression profiles,the analysis showed that the difference between the sham operation group and the model group was the largest,and the difference between the sham operation group and the Kangxianling Decoction high-dose treatment group was the smallest.So it was observed that the larger the drug treatment dose,the more the expression profile of the sample was similar to the sham operation group.Conclusion Kangxianling Decoction can improve renal fibrosis,and the better the anti-fibrosis effect with increasing dose.It is speculated that it may regulate differential expression of miRNA profiles and decreasing TGF-βand Smad3 m RNA levels to protect the kidney.
作者 蒋宇峰 朱尧焓 陈刚 何立群 JIANG Yufeng;ZHU Xiaohan;CHEN Gang;HE Liqun(Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200021,China;Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203,China)
出处 《长春中医药大学学报》 2019年第2期298-301,共4页 Journal of Changchun University of Chinese Medicine
基金 国家自然科学基金资助项目(81473626) 何立群上海名老中医学术经验研究工作室(SHGZS-2017027)
关键词 抗纤灵方 肾纤维化 阿霉素肾病 miRNA表达谱 Kangxianling Decoction renal fibrosis adriamycin nephropathy profiles of miRNA expression
  • 相关文献

参考文献3

二级参考文献32

  • 1沙朝晖,付平,周莉,唐万欣,柳飞,李静.大鼠5/6肾切除慢性肾功能衰竭动物模型的实验研究[J].四川动物,2006,25(3):632-634. 被引量:42
  • 2卓莉,刘伏友,彭佑铭,周凌辉,刘映红,刘虹,许向青.一种新型腹膜纤维化大鼠模型的构建[J].中华肾脏病杂志,2005,21(8):495-497. 被引量:12
  • 3郑莜萸.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002.374.
  • 4Mecalf PA, Scragg RK. Comparison of WHO and AD Acrteria for di- agnosis of glucose status in a duhs[ J ]. Diabetes Res Clin Pract,2000, 49(2) :169 - 180.
  • 5Liu Y. Renal fibrosis : New insights into the pathogenesis and thera- peutics [ J ]. Kidney Int,2006,69 : 213 - 217.
  • 6Stanghellini V, Ghifini C, Macearini MR, et al. Fsating and postprandi- al gastrointestinal motility in utcer and non-ulcer dyspepsia[ J ]. Gut, 1992,33 : 184 - 186.
  • 7Bottinger EP, Bitzer M. TGF - 13 signaling in renal disease [ J ]. J Am Soc Nephrol,2002,13 (10) :2600 - 2610.
  • 8Stambe C,Atkins R C,Tesch G H,et al. The Role of p38 alpha Mito- gen - Activated Protein Kinase activation in renal fibrosis [ J ]. J Am Soc Nephro1,2004,15 ( 2 ) :370 - 379.
  • 9俞娅芬,董吉祥.TGF-β在慢性肾脏疾病中的作用[J].国外陕学:泌尿系统分册,2005,25(1):568-571.
  • 10Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Ce11,2004,116 (2) :281 - 297.

共引文献16

同被引文献113

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部